Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials

Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury: The EDEN Randomized Trial

(2012) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized, Placebo-controlled Clinical Trial of an Aerosolized β2-Agonist for Treatment of Acute Lung Injury

(2011)   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Enteral Omega-3 Fatty Acid, γ-Linolenic Acid, and Antioxidant Supplementation in Acute Lung Injury

(2011) Todd W. Rice   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Acute Lung Injury in Patients With Traumatic Injuries: Utility of a Panel of Biomarkers for Diagnosis and Pathogenesis

(2010) Richard D. Fremont et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Prognostic and Pathogenetic Value of Combining Clinical and Biochemical Indices in Patients With Acute Lung Injury

(2009) Lorraine B. Ware et al.   CHEST

Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury

(2008) Kathleen D. Liu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Predictors of mortality in acute lung injury during the era of lung protective ventilation

(2008) E Seeley et al.   THORAX

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

(2008) C S Calfee et al.   THORAX